Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Murphy

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Virology|March 31, 2004
Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genesStéphane Biacchesi, Mario H Skiadopoulos, Kim C Tran, et al.
Journal of Virology|September 15, 2005
Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidatesStéphane Biacchesi, Quynh N Pham, Mario H Skiadopoulos, et al.
Journal of Virology|May 30, 2006
Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primatesStéphane Biacchesi, Quynh N Pham, Mario H Skiadopoulos, et al.
Virology Journal|July 4, 2007
Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genesEmmalene J Bartlett, Adam Castaño, Sonja R Surman, et al.
Vaccine|September 25, 2003
Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeysStephen S Whitehead, Kathryn A Hanley, Joseph E Blaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2004
Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityUrsula J Buchholz, Alexander Bukreyev, Lijuan Yang, et al.
The American Journal of Tropical Medicine and Hygiene|January 12, 2005
Genetically modified, live attenuated dengue virus type 3 vaccine candidatesJoseph E Blaney, Christopher T Hanson, Cai-Yen Firestone, et al.
Virology Journal|February 13, 2008
La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeysRichard S Bennett, Christina M Cress, Jerrold M Ward, et al.
Journal of Virology|December 5, 2008
The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infectionJim B Boonyaratanakornkit, Emmalene J Bartlett, Emerito Amaro-Carambot, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceHimani Bisht, Anjeanette Roberts, Leatrice Vogel, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Virology|March 31, 2004
Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genesStéphane Biacchesi, Mario H Skiadopoulos, Kim C Tran, et al.
Journal of Virology|September 15, 2005
Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidatesStéphane Biacchesi, Quynh N Pham, Mario H Skiadopoulos, et al.
Journal of Virology|May 30, 2006
Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primatesStéphane Biacchesi, Quynh N Pham, Mario H Skiadopoulos, et al.
Virology Journal|July 4, 2007
Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genesEmmalene J Bartlett, Adam Castaño, Sonja R Surman, et al.
Vaccine|September 25, 2003
Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeysStephen S Whitehead, Kathryn A Hanley, Joseph E Blaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2004
Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityUrsula J Buchholz, Alexander Bukreyev, Lijuan Yang, et al.
The American Journal of Tropical Medicine and Hygiene|January 12, 2005
Genetically modified, live attenuated dengue virus type 3 vaccine candidatesJoseph E Blaney, Christopher T Hanson, Cai-Yen Firestone, et al.
Virology Journal|February 13, 2008
La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeysRichard S Bennett, Christina M Cress, Jerrold M Ward, et al.
Journal of Virology|December 5, 2008
The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infectionJim B Boonyaratanakornkit, Emmalene J Bartlett, Emerito Amaro-Carambot, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceHimani Bisht, Anjeanette Roberts, Leatrice Vogel, et al.
Pageof 13